Search the Archive

Medicine: Hormonal Birth Control / Langhart Death #1081562

CNN Evening News for Monday, Apr 06, 2015
View other clips in this broadcast →

Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws.

(Studio: Anderson Cooper) The controversy over a type of birth control introduced.

(New York: Randi Kaye) The legal case around Erica Langhart%, whose 2011 death may be linked to NuvaRing% birth control, examined; details given about how Merck's NuvaRing works by releasing hormones & the blood clot risk. [Parents Rick & Karen LANGHART@- talk about their daughter, her heart attacks & death.] [NuvaRing user Megan HENRY - talks about her health issues linked to the device.] A statement from Merck about the risks quoted. Merck's statement about the NuvaRing quoted & the monitoring of birth control discussed.

Cooper, Anderson;
Kaye, Randi

Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.

Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:

  • You may request a loan of this video by registering on our website and placing an order.
  • You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
  • If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.

If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.